$LRMR·4

ZAFGEN, INC. · Jan 31, 5:31 PM ET

ZAFGEN, INC. 4

4 · ZAFGEN, INC. · Filed Jan 31, 2017

Insider Transaction Report

Form 4
Period: 2017-01-27
KIM DENNIS D
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-01-27+88,00088,000 total
    Exercise: $4.05Exp: 2027-01-27Common Stock (88,000 underlying)
Footnotes (1)
  • [F1]25% of this option vests on January 27, 2018, and the remainder vests in equal monthly installments thereafter over 36 months.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION